Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
作者信息
Maron Bradley A, Humbert Marc
机构信息
Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School and Dept of Cardiology, Boston VA Healthcare System, Boston, MA, USA
Université Paris-Saclay, INSERM UMR_S 999, AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
出版信息
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.00962-2020. Print 2020 Jul.
Abstract
摘要
相似文献
1
Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.为肺动脉高压中肺血管阻力难题增添了重要一环。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.00962-2020. Print 2020 Jul.
2
Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension.肺血管阻力在肺动脉高压患者中的临床应用
J Cardiothorac Surg. 2021 Oct 20;16(1):311. doi: 10.1186/s13019-021-01696-4.
3
Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?肺动脉高压中的肺血管阻力：关键因素？
Am J Respir Crit Care Med. 2021 Feb 15;203(4):524-525. doi: 10.1164/rccm.202009-3664LE.
4
Reply to Weatherald : Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?对韦瑟罗尔德的回复：肺动脉高压中的肺血管阻力：关键因素？
Am J Respir Crit Care Med. 2021 Feb 15;203(4):525-526. doi: 10.1164/rccm.202010-3834LE.
5
Assessing the cancer hypothesis of pulmonary arterial hypertension: the devil is in the detail.评估肺动脉高压的癌症假说：细节决定成败。
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1140-L1141. doi: 10.1152/ajplung.00084.2020. Epub 2020 Mar 18.
6
Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?多组学：通往理解肺动脉高压之路的下一步？
Thorax. 2019 Apr;74(4):317-318. doi: 10.1136/thoraxjnl-2018-212840. Epub 2019 Jan 24.
7
Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.剖析肺动脉高压中的大熔炉现象
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1329-1331. doi: 10.1164/rccm.202001-0156ED.
8
Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.关卡激酶1促进肺动脉高压的发展。
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24.
9
A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.一种用于肺动脉高压免疫调节的新型肽。
Am J Respir Crit Care Med. 2019 Jun 15;199(12):1460-1461. doi: 10.1164/rccm.201902-0388ED.
10
Real-World Data for Pulmonary Arterial Hypertension.肺动脉高压的真实世界数据。
Chest. 2019 Apr;155(4):653-654. doi: 10.1016/j.chest.2019.01.031.
引用本文的文献
1
Cardiovascular Diseases That Have Emerged From the Darkness.心血管疾病从黑暗中浮现。
J Am Heart Assoc. 2021 Oct 19;10(20):e021095. doi: 10.1161/JAHA.121.021095. Epub 2021 Oct 8.
本文引用的文献
1
Pulmonary arterial hypertension with below threshold pulmonary vascular resistance.肺动脉高压伴低于阈值的肺血管阻力。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01654-2019. Print 2020 Jul.
2
Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.系统性硬化症患者的血流动力学表型与生存：新肺动脉高压定义的影响。
Ann Rheum Dis. 2020 Mar;79(3):370-378. doi: 10.1136/annrheumdis-2019-216476. Epub 2019 Dec 9.
3
Correspondence on the debate regarding the haemodynamic definition of pulmonary hypertension.关于肺动脉高压血流动力学定义辩论的通信
Eur Respir J. 2019 Jun 5;53(6). doi: 10.1183/13993003.00727-2019. Print 2019 Jun.
4
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.血流动力学定义和肺动脉高压的最新临床分类。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
5
Identifying early pulmonary arterial hypertension in patients with systemic sclerosis.识别系统性硬化症患者中的早期肺动脉高压。
Eur Respir J. 2018 Apr 4;51(4). doi: 10.1183/13993003.00495-2018. Print 2018 Apr.
6
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.肺动脉高压的风险评估、预后和指南实施。
Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.00889-2017. Print 2017 Aug.
7
Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era: A Review.当代肺动脉高压的诊断、治疗及临床管理：综述
JAMA Cardiol. 2016 Dec 1;1(9):1056-1065. doi: 10.1001/jamacardio.2016.4471.
8
Initial dual oral combination therapy in pulmonary arterial hypertension.肺动脉高压的初始双联口服联合治疗。
Eur Respir J. 2016 Jun;47(6):1727-36. doi: 10.1183/13993003.02043-2015. Epub 2016 Mar 17.
9
Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.大型患者队列中边缘性肺动脉高压与死亡率和住院率的关联：来自退伍军人事务部临床评估、报告和跟踪项目的见解
Circulation. 2016 Mar 29;133(13):1240-8. doi: 10.1161/CIRCULATIONAHA.115.020207. Epub 2016 Feb 12.
10
Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 study.在III期CHEST-1研究中使用缓解阈值标准评估治疗反应。
J Heart Lung Transplant. 2015 Mar;34(3):348-55. doi: 10.1016/j.healun.2015.02.003. Epub 2015 Feb 16.
Zotero 插件